POMALIDOMIDE VIATRIS 1 mg, hard capsule 14 capsules
Active ingredients: Pomalidomide
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule14 capsulesorale
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- POMALIDOMIDE VIATRIS 1 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 14 plaquettes PVC polychlortrifluoroéthylène aluminium de 1 gélule
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66930463CIP73029126CIP133400930291269Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POMALIDOMIDEgélule | 1 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.